Skip to content
In deliveryUnited KingdomServices£400,000

Impede-PKD Investigational drug trial

Published
Published 12 June 2024
Deadline
Closed 27 August 2024

Overview

MPEDE-PKD is a clinical trial looking to recruit 300 participants in the UK for a randomised placebo-controlled trial of Metformin XR 500mg. We are looking for bidders who have the capability to purchase or manufacture Metformin and an identical placebo, package and label them to our requirements and distribute to 35-40 NHS Trusts across the UK

Key details

Country
United Kingdom
Status
In delivery
Category
Services
Estimated value
£400,000
Procedure
Open
Published
12 June 2024
Deadline
Closed
Classification (CPV)
Pharmacy services

Award outcome

Awarded value
£400,000
Award date
13 February 2025
Contract period
— → 24 March 2029
Winner
  • Sharp Clinical Services (UK) Ltd

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    28 February 2025

    View notice ↗
  2. Tender Update

    25 July 2024

    View notice ↗
  3. Contract Notice

    25 July 2024

    View notice ↗
  4. Prior Information Notice

    12 June 2024

    View notice ↗

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Impede-PKD Investigational drug trial — won by Sharp Clinical Services (UK) Ltd — Skim